Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Regulus Therapeutics. United States. Announced Date 04/10/2012. Closed Date 09/10/2012. Deal value: $45m. Initial public offering. Industry: Regulus Therapeutics is a biopharmaceutical company focused on the development of microRNA-based therapeutics.